Diabetes Management Journal intends to publish peer-reviewed, original articles that address the global health concerns related to diabetes. It provides clinicians with the latest findings and opinions on the optimum therapies to check the ever expanding diabetes. It is an open access, online, international journal with a primary objective to reach the readers and researchers globally.
Diabetes Management presents findings, analysis and commentary on the battle with Type I and Type II diabetes. Articles published in Diabetes Management address improvements in current therapeutics and patient compliance together with perspectives on future prospects. Coverage focuses on the key objective of stabilizing blood glucose levels in individuals with either form of the disease, and the associated issues of patient co operation and education. The journal also reflects the frontiers of current research, such as attempts to recreate pancreatic cells through stem cell technology or islet cell transplantation, the development of a vaccine for Type 1 disease and the potential for biomarkers to be used for the detection. The increasing understanding of the molecular basis of the disease and associated genetics will play an important part in future diabetes management.
The journal encourages broader research perspectives including Clinical Care, Education and Nutrition to fight diabetes. The journal also focuses on aspects involving Psychosocial Research, Epidemiology, Health Services Research on Emerging Treatments and Technologies to deal with Pathophysiology, Complications, Cardiovascular and Metabolic Risk.
INDEXING: EMBASE, Excerpta Medica, CAS (Chemical Abstracts Service), EMCare, CNKI (China National Knowledge Infrastructure)
Submit your manuscripts through Editorial Manager®: www.editorialmanager.com/openaccessjournals
Contact Editorial Office at [email protected] / [email protected]
Case Report p. 355-362
Author(s): Connie A Valdez*, Leah Fitzgeral & Sarah Ziherl Hormachea
Introduction: A U-500R Insulin Program was implemented for patients requiring >200 units of insulin. Similar to U-100 insulin, titration was based on patient BG logs. However, there was c..
Case Report p. 363-366
Author(s): Bengur Taskiran*, Guven Baris Cansu & Goknur Yorulmaz
Localized acanthosis nigricans at the insulin injection site is a rare skin disorder in patients with diabetes mellitus. We report co-existence of acanthosis nigricans and lipoatrophy at inj..
Research Article p. 367-376
Author(s): Samuel Kotei Amon & Moses Kweku Sekyi Aikins*
Objective: To assess the economic burden associated with the management of type 2 diabetes with complications from patients of the Eastern Regional Hospital’s Diabetic Clinic of the Ea..
Short Communication p. 377-382
Author(s): Chung-Mei Ouyang*
Type 2 diabetes is a significant public health concern. Food intake has been strongly linked with obesity and diabetes, not only related to the volume of food but also in terms of the compos..